Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COnCERTO: Neoadjuvant Chemotherapy for Obstructive Colon Cancer First Treated by Colostomy
2021-002588-23Phase 3Active
- Sponsor
- Rouen University Hospital
- Start
- Jan 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxaliplatin, capecitabine, fluorouracil and levoleucovorin in colon cancer (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Full curative therapeutic sequence completion. Started Jan 2023; status: active.
02
Drugs
oxaliplatincapecitabinefluorouracillevoleucovorin
03
Conditions
colon cancer
Beyond the preview
Go deeper on 2021-002588-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002588-23.